ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Cytomegalovirus Envelope Glycoprotein B Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-4G10102
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Human Cytomegalovirus Envelope Glycoprotein B Market Insights Forecast to 2028
BUY CHAPTERS

Global Human Cytomegalovirus Envelope Glycoprotein B Market Research Report 2025

Code: QYRE-Auto-4G10102
Report
January 2025
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astellas Pharma Inc
Trellis Bioscience, Inc.
Vakzine Projekt Management GmbH
VBI Vaccine Inc
Vical Incorporated

Human Cytomegalovirus Envelope Glycoprotein B Market

The global market for Human Cytomegalovirus Envelope Glycoprotein B was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Human Cytomegalovirus Envelope Glycoprotein B is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Human Cytomegalovirus Envelope Glycoprotein B is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Human Cytomegalovirus Envelope Glycoprotein B include Astellas Pharma Inc., Trellis Bioscience, Inc., Vakzine Projekt Management GmbH, VBI Vaccine Inc, Vical Incorporated, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Cytomegalovirus Envelope Glycoprotein B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Cytomegalovirus Envelope Glycoprotein B.
The Human Cytomegalovirus Envelope Glycoprotein B market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Cytomegalovirus Envelope Glycoprotein B market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Cytomegalovirus Envelope Glycoprotein B manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Cytomegalovirus Envelope Glycoprotein B Market Report

Report Metric Details
Report Name Human Cytomegalovirus Envelope Glycoprotein B Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Astellas Pharma Inc., Trellis Bioscience, Inc., Vakzine Projekt Management GmbH, VBI Vaccine Inc, Vical Incorporated
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Cytomegalovirus Envelope Glycoprotein B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Cytomegalovirus Envelope Glycoprotein B in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Human Cytomegalovirus Envelope Glycoprotein B Market report?

Ans: The main players in the Human Cytomegalovirus Envelope Glycoprotein B Market are Astellas Pharma Inc., Trellis Bioscience, Inc., Vakzine Projekt Management GmbH, VBI Vaccine Inc, Vical Incorporated

What are the Application segmentation covered in the Human Cytomegalovirus Envelope Glycoprotein B Market report?

Ans: The Applications covered in the Human Cytomegalovirus Envelope Glycoprotein B Market report are Infectious Disease, Oncology, Women's Health, Others

What are the Type segmentation covered in the Human Cytomegalovirus Envelope Glycoprotein B Market report?

Ans: The Types covered in the Human Cytomegalovirus Envelope Glycoprotein B Market report are CSJ-148, CyMVectin, TRL-345, PPCM, Cytomegalovirus Vaccine, Others

Recommended Reports

Vaccine Markets

Antibodies & Immunoglobulin

Cytomegalovirus & Related

1 Human Cytomegalovirus Envelope Glycoprotein B Market Overview
1.1 Product Definition
1.2 Human Cytomegalovirus Envelope Glycoprotein B by Type
1.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Value Comparison by Type (2024 VS 2031)
1.2.2 CSJ-148
1.2.3 CyMVectin
1.2.4 TRL-345
1.2.5 PPCM
1.2.6 Cytomegalovirus Vaccine
1.2.7 Others
1.3 Human Cytomegalovirus Envelope Glycoprotein B by Application
1.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Value by Application (2024 VS 2031)
1.3.2 Infectious Disease
1.3.3 Oncology
1.3.4 Women's Health
1.3.5 Others
1.4 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Estimates and Forecasts
1.4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue 2020-2031
1.4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales 2020-2031
1.4.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Human Cytomegalovirus Envelope Glycoprotein B Market Competition by Manufacturers
2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Manufacturers (2020-2025)
2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Human Cytomegalovirus Envelope Glycoprotein B, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, Product Type & Application
2.7 Global Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, Date of Enter into This Industry
2.8 Global Human Cytomegalovirus Envelope Glycoprotein B Market Competitive Situation and Trends
2.8.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Human Cytomegalovirus Envelope Glycoprotein B Players Market Share by Revenue
2.8.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Scenario by Region
3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region: 2020-2031
3.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region: 2020-2025
3.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region: 2026-2031
3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region: 2020-2031
3.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region: 2020-2025
3.3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region: 2026-2031
3.4 North America Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Country
3.4.1 North America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2031)
3.4.3 North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Country
3.5.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2031)
3.5.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Region
3.6.1 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2020-2031)
3.6.3 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Country
3.7.1 Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2031)
3.7.3 Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2031)
3.8.3 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2020-2031)
4.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2020-2025)
4.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2026-2031)
4.1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2020-2031)
4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2020-2031)
4.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2020-2025)
4.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2026-2031)
4.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2020-2031)
4.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2020-2031)
5 Segment by Application
5.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2031)
5.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2020-2025)
5.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2026-2031)
5.1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2020-2031)
5.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2020-2031)
5.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2020-2025)
5.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2026-2031)
5.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2020-2031)
5.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Astellas Pharma Inc.
6.1.1 Astellas Pharma Inc. Company Information
6.1.2 Astellas Pharma Inc. Description and Business Overview
6.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
6.1.5 Astellas Pharma Inc. Recent Developments/Updates
6.2 Trellis Bioscience, Inc.
6.2.1 Trellis Bioscience, Inc. Company Information
6.2.2 Trellis Bioscience, Inc. Description and Business Overview
6.2.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
6.2.5 Trellis Bioscience, Inc. Recent Developments/Updates
6.3 Vakzine Projekt Management GmbH
6.3.1 Vakzine Projekt Management GmbH Company Information
6.3.2 Vakzine Projekt Management GmbH Description and Business Overview
6.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
6.3.5 Vakzine Projekt Management GmbH Recent Developments/Updates
6.4 VBI Vaccine Inc
6.4.1 VBI Vaccine Inc Company Information
6.4.2 VBI Vaccine Inc Description and Business Overview
6.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2020-2025)
6.4.4 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
6.4.5 VBI Vaccine Inc Recent Developments/Updates
6.5 Vical Incorporated
6.5.1 Vical Incorporated Company Information
6.5.2 Vical Incorporated Description and Business Overview
6.5.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
6.5.5 Vical Incorporated Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Cytomegalovirus Envelope Glycoprotein B Industry Chain Analysis
7.2 Human Cytomegalovirus Envelope Glycoprotein B Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Cytomegalovirus Envelope Glycoprotein B Production Mode & Process Analysis
7.4 Human Cytomegalovirus Envelope Glycoprotein B Sales and Marketing
7.4.1 Human Cytomegalovirus Envelope Glycoprotein B Sales Channels
7.4.2 Human Cytomegalovirus Envelope Glycoprotein B Distributors
7.5 Human Cytomegalovirus Envelope Glycoprotein B Customer Analysis
8 Human Cytomegalovirus Envelope Glycoprotein B Market Dynamics
8.1 Human Cytomegalovirus Envelope Glycoprotein B Industry Trends
8.2 Human Cytomegalovirus Envelope Glycoprotein B Market Drivers
8.3 Human Cytomegalovirus Envelope Glycoprotein B Market Challenges
8.4 Human Cytomegalovirus Envelope Glycoprotein B Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Astellas Pharma Inc
Trellis Bioscience, Inc.
Vakzine Projekt Management GmbH
VBI Vaccine Inc
Vical Incorporated
List of Tables
 Table 1. Global Human Cytomegalovirus Envelope Glycoprotein B Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Human Cytomegalovirus Envelope Glycoprotein B Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Human Cytomegalovirus Envelope Glycoprotein B Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Human Cytomegalovirus Envelope Glycoprotein B Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Human Cytomegalovirus Envelope Glycoprotein B, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, Product Type & Application
 Table 12. Global Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Human Cytomegalovirus Envelope Glycoprotein B by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Cytomegalovirus Envelope Glycoprotein B as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2020-2025)
 Table 19. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2026-2031)
 Table 21. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2020-2025)
 Table 23. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2026-2031)
 Table 25. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2020-2025)
 Table 53. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2026-2031)
 Table 54. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2020-2025)
 Table 57. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2026-2031)
 Table 58. Global Human Cytomegalovirus Envelope Glycoprotein B Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Human Cytomegalovirus Envelope Glycoprotein B Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2020-2025)
 Table 63. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2026-2031)
 Table 64. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2020-2025)
 Table 67. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2026-2031)
 Table 68. Global Human Cytomegalovirus Envelope Glycoprotein B Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Human Cytomegalovirus Envelope Glycoprotein B Price (USD/Pcs) by Application (2026-2031)
 Table 70. Astellas Pharma Inc. Company Information
 Table 71. Astellas Pharma Inc. Description and Business Overview
 Table 72. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product
 Table 74. Astellas Pharma Inc. Recent Developments/Updates
 Table 75. Trellis Bioscience, Inc. Company Information
 Table 76. Trellis Bioscience, Inc. Description and Business Overview
 Table 77. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product
 Table 79. Trellis Bioscience, Inc. Recent Developments/Updates
 Table 80. Vakzine Projekt Management GmbH Company Information
 Table 81. Vakzine Projekt Management GmbH Description and Business Overview
 Table 82. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product
 Table 84. Vakzine Projekt Management GmbH Recent Developments/Updates
 Table 85. VBI Vaccine Inc Company Information
 Table 86. VBI Vaccine Inc Description and Business Overview
 Table 87. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product
 Table 89. VBI Vaccine Inc Recent Developments/Updates
 Table 90. Vical Incorporated Company Information
 Table 91. Vical Incorporated Description and Business Overview
 Table 92. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product
 Table 94. Vical Incorporated Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Human Cytomegalovirus Envelope Glycoprotein B Distributors List
 Table 98. Human Cytomegalovirus Envelope Glycoprotein B Customers List
 Table 99. Human Cytomegalovirus Envelope Glycoprotein B Market Trends
 Table 100. Human Cytomegalovirus Envelope Glycoprotein B Market Drivers
 Table 101. Human Cytomegalovirus Envelope Glycoprotein B Market Challenges
 Table 102. Human Cytomegalovirus Envelope Glycoprotein B Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Human Cytomegalovirus Envelope Glycoprotein B
 Figure 2. Global Human Cytomegalovirus Envelope Glycoprotein B Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Type: 2024 & 2031
 Figure 4. CSJ-148 Product Picture
 Figure 5. CyMVectin Product Picture
 Figure 6. TRL-345 Product Picture
 Figure 7. PPCM Product Picture
 Figure 8. Cytomegalovirus Vaccine Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Human Cytomegalovirus Envelope Glycoprotein B Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application: 2024 & 2031
 Figure 12. Infectious Disease
 Figure 13. Oncology
 Figure 14. Women's Health
 Figure 15. Others
 Figure 16. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (2020-2031) & (K Pcs)
 Figure 19. Global Human Cytomegalovirus Envelope Glycoprotein B Average Price (USD/Pcs) & (2020-2031)
 Figure 20. Human Cytomegalovirus Envelope Glycoprotein B Report Years Considered
 Figure 21. Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Manufacturers in 2024
 Figure 22. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Human Cytomegalovirus Envelope Glycoprotein B Players: Market Share by Revenue in Human Cytomegalovirus Envelope Glycoprotein B in 2024
 Figure 24. Human Cytomegalovirus Envelope Glycoprotein B Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2020-2031)
 Figure 27. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2020-2031)
 Figure 28. U.S. Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2020-2031)
 Figure 31. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2020-2031)
 Figure 39. China Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Taiwan Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Indonesia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Thailand Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Malaysia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Philippines Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2020-2031)
 Figure 55. Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2020-2031)
 Figure 56. Turkey Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Saudi Arabia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. U.A.E Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Global Sales Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Type (2020-2031)
 Figure 60. Global Revenue Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Type (2020-2031)
 Figure 61. Global Human Cytomegalovirus Envelope Glycoprotein B Price (USD/Pcs) by Type (2020-2031)
 Figure 62. Global Sales Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Application (2020-2031)
 Figure 63. Global Revenue Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Application (2020-2031)
 Figure 64. Global Human Cytomegalovirus Envelope Glycoprotein B Price (USD/Pcs) by Application (2020-2031)
 Figure 65. Human Cytomegalovirus Envelope Glycoprotein B Value Chain
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Human Cytomegalovirus Detection Kit Market Research Report 2024
Global Glycoprotein Analysis Market Research Report 2024
Global Human Immunoglobulin Market Research Report 2024
Global Cytomegalovirus Retinitis Treatment Market Research Report 2024
Global Phytohemagglutinin Market Research Report 2025
Global Human Papillomavirus and Cytomegalovirus Therapeutics Market Research Report 2024
Global Flow Cytometry Antibody Products Market Research Report 2025
Global Hepatitis B Human Immunoglobulin Market Research Report 2024
Global Cytomegalovirus Assay Market Research Report 2024
Global Cytomegalovirus Treatment Market Research Report 2024
Cytomegalovirus Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cytomegalovirus Disease Treatments Market Research Report 2024
Global Hepatitis C Virus Envelope Protein E2 Market Research Report 2024
Global Cytomegalovirus CMV Treatment Drugs Market Research Report 2024
Global Cytomegalovirus HHV 5 Infection Therapeutic Drugs Market Insights Forecast to 2030
Global Human Histaglobulin Market Research Report 2024
Global Mannooligosaccharides Market Research Report 2025
Global HIV Vaccine Market Research Report 2025
Global Hepatitis B Immune Globulin Market Research Report 2025
Global Streptococcus Group B Antibodies Market Research Report 2024

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions